Related Experiment Videos

Metabolic vulnerabilities of metastasizing cancer cells

Sarah-Maria Fendt1,2

  • 1Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Herestraat 49, 3000, Leuven, Belgium. sarah-maria.fendt@kuleuven.vib.be.

BMC Biology
|July 13, 2019
PubMed

Insights

Metastasis, a major cause of cancer death, presents unique metabolic vulnerabilities. Targeting these distinct cancer cell metabolisms offers new therapeutic opportunities for metastatic cancers.

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Metastasis Research

Background:

  • Metastasis formation is the primary cause of cancer-related mortality.
  • Effective treatments for metastatic cancers remain a significant clinical challenge.
  • Emerging evidence highlights distinct metabolic alterations in metastasizing cancer cells.

Purpose of the Study:

  • To explore the potential of targeting metabolic vulnerabilities in cancer cells that drive metastasis.
  • To discuss novel therapeutic strategies based on cancer cell metabolism.

Main Methods:

  • Review of recent research on cancer cell metabolism during metastasis.
  • Analysis of metabolic pathways specific to metastasizing cancer cells.
  • Discussion of potential therapeutic targets.

Main Results:

  • Metastatic cancer cells exhibit unique metabolic profiles compared to primary tumors.
  • These metabolic differences represent exploitable vulnerabilities.
  • Targeting these vulnerabilities could offer new avenues for cancer treatment.

Conclusions:

  • Exploiting the distinct metabolism of metastasizing cancer cells presents a promising therapeutic strategy.
  • Understanding cancer metabolism is crucial for developing effective treatments against metastasis.
  • Targeting metabolic vulnerabilities may lead to novel interventions for preventing and treating metastatic cancers.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K